In cell cultures expressing mutant huntingtin, treatments with either simvastatin or β-CD have demonstrated to reduce lipid content in cell membrane modifying in turn the membrane localization of N-methyl-d-aspartate (NMDA) receptors which are commonly associated with cholesterol-enriched domains in HD. Here, HTT is linked to Huntington disease.